BMO Capital on Eli Lilly (LLY): Centessa deal positive for shares; 'diversifying business ahead of any major LOEs'
Tweet Send to a Friend
BMO Capital analyst Evan Seigerman reiterated an Outperform rating and $1,300.00 price target on Eli Lilly (NYSE: LLY)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
